Offer - Urjas Oil for just ₹ 1
Kefpod CV 50 Mg/31.25 Mg Dry Syrup is a prescription drug, available for use as Syrup. Other than this, Kefpod CV 50 Mg/31.25 Mg Dry Syrup has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Kefpod CV 50 Mg/31.25 Mg Dry Syrup. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Kefpod CV 50 Mg/31.25 Mg Dry Syrup can also lead to other problems, which have been listed below. Usually, these side effects of Kefpod CV 50 Mg/31.25 Mg Dry Syrup go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Kefpod CV 50 Mg/31.25 Mg Dry Syrup is Mild for pregnant women and Moderate for women who are breastfeeding. In addition, Kefpod CV 50 Mg/31.25 Mg Dry Syrup's effects on the liver, heart and kidney are discussed below in the Kefpod CV 50 Mg/31.25 Mg Dry Syrup related warnings section.
Individuals suffering from medical conditions like Jaundice must refrain from the use of Kefpod CV 50 Mg/31.25 Mg Dry Syrup since this can cause severe adverse effects. Some other conditions that can be affected by Kefpod CV 50 Mg/31.25 Mg Dry Syrup are listed in the contraindications section below.
Additionally, Kefpod CV 50 Mg/31.25 Mg Dry Syrup may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Kefpod CV 50 Mg/31.25 Mg Dry Syrup is safe while driving, and is is addictive in nature.
Kefpod CV 50 Mg/31.25 Mg Dry Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 2 - 12 years (Child) |
|
Is the use of Kefpod CV 50 Mg/31.25 Mg Dry Syrup safe for pregnant women?
Kefpod CV has mild to no side effects in pregnant women.
Is the use of Kefpod CV 50 Mg/31.25 Mg Dry Syrup safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Kefpod CV. Immediately discontinue Kefpod CV if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Kefpod CV 50 Mg/31.25 Mg Dry Syrup on the Kidneys?
There may be some adverse effects on kidney after taking Kefpod CV. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Kefpod CV 50 Mg/31.25 Mg Dry Syrup on the Liver?
You may experience side effects on your liver after taking Kefpod CV. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Kefpod CV 50 Mg/31.25 Mg Dry Syrup on the Heart?
Kefpod CV may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Kefpod CV 50 Mg/31.25 Mg Dry Syrup unless your doctor advises you to do so -
Is this Kefpod CV 50 Mg/31.25 Mg Dry Syrup habit forming or addictive?
Kefpod CV 50 Mg/31.25 Mg Dry Syrup does not cause addiction.
Interaction between Food and Kefpod CV 50 Mg/31.25 Mg Dry Syrup
Taking Kefpod CV 50 Mg/31.25 Mg Dry Syrup with food does not harm your health.
Interaction between Alcohol and Kefpod CV 50 Mg/31.25 Mg Dry Syrup
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Kefpod CV 50 Mg/31.25 Mg Dry Syrup.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
